Liposome toxicity in the mouse central nervous system

Area of Science:

• Neuroscience
• Biomedical Engineering
• Drug Delivery Systems

Background:

• Liposomes are versatile lipid-based nanoparticles used in drug delivery.
• Their application in the central nervous system (CNS) is limited by potential toxicity.
• Understanding liposome composition-toxicity relationships is crucial for CNS-targeted therapies.

Purpose of the Study:

• To evaluate the neurotoxicity of different liposome formulations.
• To determine the safety of specific liposome compositions for CNS delivery.
• To identify liposome characteristics suitable for therapeutic agent transport into the CNS.

Main Methods:

• Comparative analysis of liposome formulations with varying lipid compositions (e.g., lecithin-cholesterol-dicetyl phosphate, lecithin-cholesterol-stearylamine, lecithin-cholesterol-phosphatidic acid, dipalmitoyl lecithin).
• Intracranial injection of liposomes into the CNS in a preclinical model.
• Histopathological examination and assessment of neurological and physiological responses post-injection.

Main Results:

• Liposomes containing dicetyl phosphate or stearylamine induced severe neurotoxicity, including epileptic seizures, respiratory failure, and tissue necrosis.
• Liposomes formulated with phosphatidic acid or solely dipalmitoyl lecithin demonstrated minimal pathological changes.
• Observed pathology in the latter group was primarily attributed to mechanical trauma by day six post-injection.

Conclusions:

• Liposome composition is a critical determinant of CNS safety and tolerability.
• Specific formulations, such as those with phosphatidic acid or dipalmitoyl lecithin, show promise for CNS applications.
• Benign liposome formulations could serve as effective carriers for therapeutic agents targeting the central nervous system.